chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 13.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, MNQ
Symptoms: Facial paresis, Full blood count, Guillain-Barre syndrome, Lumbar puncture, Muscular weakness
Clinical narrative: Weakness of legs, upper extremity, facial weakness rash all over body - was diagnosed with GB syndrome and hospitalized for IVIG and LP 7/25/07-records received -DX: Guillain Barre. Day before admission 5/18/07-developed macular papular rash on face and headache pain in both legs, shortness of breath. Admitted on 5/19/07-  Unsuccessful spinal tap. Treated with IVIG and there was no progressive loss of muscle tone no loss of sensation. Good muscle tone
Age: 13.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, MNQ
Symptoms: Facial paresis, Guillain-Barre syndrome, Immunoglobulins, Lumbar puncture, Muscular weakness
Clinical narrative: Weakness of legs, upper extremity, facial weakness rash all over body - was diagnosed with GB syndrome and hospitalized for IVIG and LP 7/25/07-records received -DX: Guillain Barre. Day before admission 5/18/07-developed macular papular rash on face and headache pain in both legs, shortness of breath. Admitted on 5/19/07-  Unsuccessful spinal tap. Treated with IVIG and there was no progressive loss of muscle tone no loss of sensation. Good muscle tone
Age: 13.0
Sex: F
Vaccine: HPV4, MNQ, HPV4, MNQ
Symptoms: Rash generalised
Clinical narrative: Weakness of legs, upper extremity, facial weakness rash all over body - was diagnosed with GB syndrome and hospitalized for IVIG and LP 7/25/07-records received -DX: Guillain Barre. Day before admission 5/18/07-developed macular papular rash on face and headache pain in both legs, shortness of breath. Admitted on 5/19/07-  Unsuccessful spinal tap. Treated with IVIG and there was no progressive loss of muscle tone no loss of sensation. Good muscle tone
Age: 1.0
Sex: F
Vaccine: HIBV, MMRV, PNC, HEP, MMRV, PNC
Symptoms: Injection site induration, Injection site swelling, Skin discolouration
Clinical narrative: Patient had induration and swelling of left leg. Not seen in clinic until 1 month after vaccine- only finding on exam was post inflammatory color changes.
Age: 1.0
Sex: F
Vaccine: HIBV, MMRV, PNC, HEP, MMRV, PNC
Symptoms: Local reaction
Clinical narrative: Patient had induration and swelling of left leg. Not seen in clinic until 1 month after vaccine- only finding on exam was post inflammatory color changes.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMRV
Symptoms: Erythema, Tenderness
Clinical narrative: Patient seen on 5/22/2007 with redness and tenderness to Right thigh.
Age: 1.3
Sex: M
Vaccine: DTAP, HEPA, MMRV, DTAP, HEPA, MMRV
Symptoms: Immediate post-injection reaction, Induration, Injection site induration, Injection site urticaria, Urticaria
Clinical narrative: Patient developed urticarial reaction at MMRV injection site shortly after immunization. Area was indurated. Patient recovered with Benadryl. Information has been received from a physician concerning a 15 month old male with no medical history or allergies who on 22-MAY-2007 evening was vaccinated SC on left leg with a first dose of MMR II (Oka/Merck upgrade process) (Lot # 657534/0474U). Concomitant therapy on the same day included a IM first dose on left leg of HEPATITIS A virus vaccine inactivated (MSD) (Lot # 652293/0248U) and a IM third dose on left leg of INFANRIX (Lot # AC14B033AA). There was no illness at the time of vaccination. On 22-MAY-2007 evening the patient developed a local reaction and returned to the office couple of days after vaccination. Unspecified medical attention was sought. At the time of report, the patient had recovered. A product quality complain was not involved. Additional information has been received from the physician who stated that the patient developed urticarial reaction at the injection site shortly after vaccination. The are was described as indurated. The patient was treated with BENADRYL. At the time of report the patient had recovered. This is one of seversl reports received from the same source. No further information is available.
Age: 1.3
Sex: M
Vaccine: DTAP, HEPA, MMRV, DTAP, HEPA, MMRV
Symptoms: Injection site induration, Injection site urticaria, Local reaction, Urticaria
Clinical narrative: Patient developed urticarial reaction at MMRV injection site shortly after immunization. Area was indurated. Patient recovered with Benadryl. Information has been received from a physician concerning a 15 month old male with no medical history or allergies who on 22-MAY-2007 evening was vaccinated SC on left leg with a first dose of MMR II (Oka/Merck upgrade process) (Lot # 657534/0474U). Concomitant therapy on the same day included a IM first dose on left leg of HEPATITIS A virus vaccine inactivated (MSD) (Lot # 652293/0248U) and a IM third dose on left leg of INFANRIX (Lot # AC14B033AA). There was no illness at the time of vaccination. On 22-MAY-2007 evening the patient developed a local reaction and returned to the office couple of days after vaccination. Unspecified medical attention was sought. At the time of report, the patient had recovered. A product quality complain was not involved. Additional information has been received from the physician who stated that the patient developed urticarial reaction at the injection site shortly after vaccination. The are was described as indurated. The patient was treated with BENADRYL. At the time of report the patient had recovered. This is one of seversl reports received from the same source. No further information is available.
Age: 72.0
Sex: M
Vaccine: VARZOS
Symptoms: Blister, Bone pain, Groin pain, Pain, Pain in extremity
Clinical narrative: Patient vaccinated with Zostavax on 5-15-07 in fight upper arm; on 5/17/07 patient was driving long distance and had pain in left groin region; "pinching sensation somewhat relieved by walking; 5/18/07 to developed deep bone pain in left shin - he rated it a '8" for scale "1-10," (10 being worst pain) 5/19/07 left shin pain throbbing persistent later that evening pain became sharp. Used Advil prn; 5/20/07 pain in same area and extended to 'entire leg throbbing." 5/21/07 Patient presented to Urgent Care local facility; knee (left) X-ray done but negative. Patient given Valtrex prescription for clustered blisters left shin - MD informed patient he needed 'for" shingles. (information obtained from pattern via phone).
Age: 72.0
Sex: M
Vaccine: VARZOS
Symptoms: X-ray normal
Clinical narrative: Patient vaccinated with Zostavax on 5-15-07 in fight upper arm; on 5/17/07 patient was driving long distance and had pain in left groin region; "pinching sensation somewhat relieved by walking; 5/18/07 to developed deep bone pain in left shin - he rated it a '8" for scale "1-10," (10 being worst pain) 5/19/07 left shin pain throbbing persistent later that evening pain became sharp. Used Advil prn; 5/20/07 pain in same area and extended to 'entire leg throbbing." 5/21/07 Patient presented to Urgent Care local facility; knee (left) X-ray done but negative. Patient given Valtrex prescription for clustered blisters left shin - MD informed patient he needed 'for" shingles. (information obtained from pattern via phone).
Age: 11.0
Sex: F
Vaccine: HPV4, TTOX
Symptoms: Arthritis, C-reactive protein, Full blood count, Oedema peripheral, Pain in extremity
Clinical narrative: Painful, swollen left heel without trauma arthritis left foot.
Age: 11.0
Sex: F
Vaccine: HPV4, TTOX
Symptoms: Red blood cell sedimentation rate, X-ray limb
Clinical narrative: Painful, swollen left heel without trauma arthritis left foot.
Age: 13.0
Sex: F
Vaccine: TDAP
Symptoms: Body temperature increased, Rash
Clinical narrative: Rash to front of neck and back of neck and chest at 1140 am Benadryl 50mg injected IM to right deltoid. T 99.8, P 80, B/P 106/70. 1155 - T 99.1, P80, R20, B/P 110/60. 1220 - T98.8, P80, R20, B/P 110/80. 12:00pm rash was cleared up.
Age: 24.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Injection site nodule
Clinical narrative: Approximately 3/4cm nodule at injection site
Age: 24.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Injection site swelling, Mass
Clinical narrative: Approximately 3/4cm nodule at injection site
Age: 14.0
Sex: F
Vaccine: HPV4
Symptoms: Laboratory test, Urticaria
Clinical narrative: Urticarial rash began about 24 hours after vaccines were given patient also had bloodwork drawn after receiving her vaccine. Patient returned to office 2 days after vaccine was given; rash improved with Benadryl somewhat completely improved with Atarax.
Age: 1.0
Sex: M
Vaccine: HEPA, MMRV, PNC
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: Left leg developed 1 1/2 inches round red hard circle. Not warm, raised or painful. Continue observation and call MD of becomes painful or changes.
Age: 77.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain, Paraesthesia, Rash
Clinical narrative: Patient developed an occipital rash 3 days after receiving the Zostavax shot. She has had a burning pain over the area and tingling. Treatment - use ice topically, Medrol dose pack, Valtrex 1000mg TID
Age: 8.0
Sex: M
Vaccine: VARCEL, VARCEL
Symptoms: Eyelid oedema, Vomiting
Clinical narrative: Twenty minutes after receiving Varicella vaccine, patient returned to clinic with swollen right eyelid and had vomited x 1. Gave patient 35mg Benadryl and held in office for 40-45 minutes. Swelling had decreased by the time patient left. No signs of respiratory distress.
Age: 8.0
Sex: M
Vaccine: VARCEL, VARCEL
Symptoms: Eye swelling, Rash, Vomiting
Clinical narrative: Twenty minutes after receiving Varicella vaccine, patient returned to clinic with swollen right eyelid and had vomited x 1. Gave patient 35mg Benadryl and held in office for 40-45 minutes. Swelling had decreased by the time patient left. No signs of respiratory distress.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV
Symptoms: Injection site erythema, Injection site oedema, Injection site pruritus, Injection site swelling
Clinical narrative: Patient received DTaP right deltoid 5/21/07 in afternoon of 5/22/07 - Mother (legal guardian) called clinic to report swelling, redness, itching over right deltoid. Told to come in, came in AM 5/23/07 - afebrile, fullness right arm; full strength, pulse intact deltoid edematous, erythematous, no erythema or d/c from injection site erythema extend  of the way to elbow.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Redness and pain on IM injection site with progressive exacerbation noted 2days after administration.
Age: 5.0
Sex: F
Vaccine: DTAP
Symptoms: Injection site swelling
Clinical narrative: Left deltoid noticed yesterday 5/21/07 swollen apply ice, rest, elevate
Age: 3.0
Sex: M
Vaccine: HEPA
Symptoms: Rash, Rash papular
Clinical narrative: Rash to left forearm - patch of papular ery rash and to buttocks, upper legs and at waist line.
Age: 0.2
Sex: M
Vaccine: DTAPHEPBIP, HIBV
Symptoms: Injection site nodule
Clinical narrative: Left thigh has a 1/2cm nodule where the IZ" where administered.
Age: 45.0
Sex: F
Vaccine: TD
Symptoms: Cellulitis, White blood cell count normal
Clinical narrative: 49 year old female received Td on 02/23/07 developed cellulitis of L arm on 2/27/07. Had to take antibiotics.
Age: 4.0
Sex: F
Vaccine: DTAP
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site swelling
Clinical narrative: Swollen left deltoid 8cm x 7cm each warm, noticed yesterday night, hard reddish, tenderness. No pain.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: CSF test abnormal, Enterovirus serology test negative, Herpes simplex serology negative, Meningitis aseptic, Pain in extremity
Clinical narrative: Information has been received from the Centers for Disease Control (VAERS # 187837) lab concerning a 44 month old male with no previous history of disease or immunosuppressive illness, who on 19-AUG-1999 was vaccinated with a dose of Varivax. On 27-APR-2002 the patient developed a zoster-like rash. On 30-APR-2002 the patient was admitted to the hospital with aseptic meningitis. CSF PCR performed for herpes simplex and enterovirus were negative and VZV was positive. The VZV was confirmed to be vaccine strain by the CDC lab. The patient was treated with IV acyclovir and had rapid improvement. No further information was provided. Additional information is not expected.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Rash vesicular, Varicella zoster virus serology positive, Viral DNA test positive
Clinical narrative: Information has been received from the Centers for Disease Control (VAERS # 187837) lab concerning a 44 month old male with no previous history of disease or immunosuppressive illness, who on 19-AUG-1999 was vaccinated with a dose of Varivax. On 27-APR-2002 the patient developed a zoster-like rash. On 30-APR-2002 the patient was admitted to the hospital with aseptic meningitis. CSF PCR performed for herpes simplex and enterovirus were negative and VZV was positive. The VZV was confirmed to be vaccine strain by the CDC lab. The patient was treated with IV acyclovir and had rapid improvement. No further information was provided. Additional information is not expected.
Age: 4.0
Sex: M
Vaccine: VARCEL, DTAP, MMR
Symptoms: Agitation, Body temperature increased, Flushing, Oxygen saturation, Pruritus
Clinical narrative: Information has been received from a registered nurse concerning a 4 year old male with cleft lip, no known drug allergies and a history of trouble breathing within 30 minutes of administration of MMR who on 13 Oct 2005 at noon was vaccinated SC in the right deltoid with a first dose of Varivax. There was no illness at the time of vaccination. Ten minutes after vaccination the patient complained of itching especially on his scalp, became agitated, and had generally flushed skin. There was no rash, hives, wheezing or rhonci. The patient's pulse ox was on room air was 93-94% and temperature was 100 by ear. The patient was treated with Tylenol 160mg/5mL tsp and Benadryl 12.5 mg IM. The patient slept and awoke 30 minutes later with less itching. It was reported that the patient recovered on 13 Oct 2005. It was reported that the patient had an adverse event following vaccination with Dtap on 02 Sep 2005. Additional information is not expected.
Age: 4.0
Sex: M
Vaccine: VARCEL, DTAP, MMR
Symptoms: Reaction to previous exposure to any vaccine
Clinical narrative: Information has been received from a registered nurse concerning a 4 year old male with cleft lip, no known drug allergies and a history of trouble breathing within 30 minutes of administration of MMR who on 13 Oct 2005 at noon was vaccinated SC in the right deltoid with a first dose of Varivax. There was no illness at the time of vaccination. Ten minutes after vaccination the patient complained of itching especially on his scalp, became agitated, and had generally flushed skin. There was no rash, hives, wheezing or rhonci. The patient's pulse ox was on room air was 93-94% and temperature was 100 by ear. The patient was treated with Tylenol 160mg/5mL tsp and Benadryl 12.5 mg IM. The patient slept and awoke 30 minutes later with less itching. It was reported that the patient recovered on 13 Oct 2005. It was reported that the patient had an adverse event following vaccination with Dtap on 02 Sep 2005. Additional information is not expected.
Age: 4.0
Sex: M
Vaccine: VARCEL, DTAP, MMR
Symptoms: Anaphylactic reaction, Dyspnoea, Reaction to previous exposure to any vaccine
Clinical narrative: Information has been received from a registered nurse concerning a 4 year old male with cleft lip, no known drug allergies and a history of trouble breathing within 30 minutes of administration of MMR who on 13 Oct 2005 at noon was vaccinated SC in the right deltoid with a first dose of Varivax. There was no illness at the time of vaccination. Ten minutes after vaccination the patient complained of itching especially on his scalp, became agitated, and had generally flushed skin. There was no rash, hives, wheezing or rhonci. The patient's pulse ox was on room air was 93-94% and temperature was 100 by ear. The patient was treated with Tylenol 160mg/5mL tsp and Benadryl 12.5 mg IM. The patient slept and awoke 30 minutes later with less itching. It was reported that the patient recovered on 13 Oct 2005. It was reported that the patient had an adverse event following vaccination with Dtap on 02 Sep 2005. Additional information is not expected.
Age: 1.2
Sex: M
Vaccine: VARCEL
Symptoms: Fatigue, Herpes zoster, Pyrexia, Rash vesicular
Clinical narrative: Information has been received from a physician concerning a 38-month-old male with asthma, who on 12-OCT-2001 was vaccinated in the arm with a first dose of Varivax (lot# 638245/0779L). It was unknown if there was illness at the time of vaccination. No rash occurred after the vaccine. On 08-NOV-2003 the patient developed C3-C5 vesicular rash and was diagnosed with zoster. It was associated with fever and fatigue. Unspecified medical attention was sought and he was treated with acyclovir; no diagnostic or laboratory tests were performed. Subsequently, the patient recovered from zoster. Additional information is not expected.
Age: 2.0
Sex: M
Vaccine: VARCEL
Symptoms: Herpes zoster, Varicella
Clinical narrative: Information has been received from a physician concerning a 47-month-old male with no pre-existing allergies, birth defects or medical conditions, who on 17-DEC-2001 was vaccinated with a first dose of Varivax (lot # 639781/0983L). There was no illness at the time of vaccination. On 03-SEP-2004 the patient developed a vesicular rash diagnosed as zoster. Medical attention was sought and the patient was treated with acyclovir. A PCR test was done but no results were reported. Subsequently, the patient recovered from zoster. Additional information is not expected.
Age: 5.0
Sex: F
Vaccine: VARCEL
Symptoms: Back pain, Body temperature, Cough, Herpes simplex serology negative, Herpes zoster
Clinical narrative: Information has been received from a physician concerning a 5-year-old female with asthma, anaemia who no known allergies, who on 18-SEP-2001 was vaccinated in the right thigh with a first dose of Varivax (lot# 638497/1905K). There was no illness at the time of vaccination. On 26-SEP-2005 the patient developed left thigh and vaginal area vesicular rash associated with fever, back pain and an upper respiratory infection. The rash was described as being in the L1 dermatome, it started on the left thigh and vaginal area and was localized in the L1 dermatome. The lesions were mostly vesicular, there were not hemorrhagic or itchy. They were painful, with a pain score of 4 on the Wong Baker Scale. It was not known how many spots the patient had. On 27-SEP-2005 in the morning the patient presented with a low grade fever of 99.7, as well as with complaints of back pain in the morning for two days in a row. She had a cough and runny nose, a rash on thigh, and vaginal area that the patient's mother noticed on 26-SEP-2006.  The rash consisted of vesicles and papules and was erythematous. The patient experienced pain on percussion of the left flank. She had fluid filled vesicles in rosette pattern over the left side of mons pubis with erythematous papules extending from midline to side. Also with vesicles and erythematous papules over lower left side and lower back. The patient's pain in back did correlate with the area of the rash. The patient was treated with ibuprofen (MOTRIN) 100mg/5ml 2 tsp po/6h as needed, acetaminophen (TYLENOL) and diphenhydramine hydrochloride (BENADRYL). The patient did not have a history of varicella. A skin scraping was taken on 27-SEP-2005 for HSV Antigen Detection (result-negative), HSV PCR (result-negative), VZV Antigen Detection (result-positive), VZV PCR (result-positive) and fungal dermatophyte screen. A urinalysis by dip was performed in the office, the result was normal. The patient was diagnosed with Varicella zoster. The patient was seen in the office on 28-SEP-2006 for a recheck. Since yesterday the rash had gotten worse, the papules developed into vesicles, but the pain had remained the same and was improving with acetaminophen (TYLENOL)/ibuprofen (MOTRIN). There was no spreading of the rash to other areas. There were no new fevers. The was an occasional cough. She still experienced tenderness over the left flank area, had multiple grouped vesicles in the L1 dermatomal distribution and shotty cerival adenopathy. It was reported that in the mouth prior to the zoster she received fluticasone propionate (FLOVENT) 44mcg/act in aero 2 puffs bid, albuterol 90 mcg/act in aero 2 puffs every 4 hours as needed and iron 475 mg PO. No outcome was reported. Additional information is not expected.
Age: 5.0
Sex: F
Vaccine: VARCEL
Symptoms: Pain, Pyrexia, Rash erythematous, Rhinorrhoea, Tenderness
Clinical narrative: Information has been received from a physician concerning a 5-year-old female with asthma, anaemia who no known allergies, who on 18-SEP-2001 was vaccinated in the right thigh with a first dose of Varivax (lot# 638497/1905K). There was no illness at the time of vaccination. On 26-SEP-2005 the patient developed left thigh and vaginal area vesicular rash associated with fever, back pain and an upper respiratory infection. The rash was described as being in the L1 dermatome, it started on the left thigh and vaginal area and was localized in the L1 dermatome. The lesions were mostly vesicular, there were not hemorrhagic or itchy. They were painful, with a pain score of 4 on the Wong Baker Scale. It was not known how many spots the patient had. On 27-SEP-2005 in the morning the patient presented with a low grade fever of 99.7, as well as with complaints of back pain in the morning for two days in a row. She had a cough and runny nose, a rash on thigh, and vaginal area that the patient's mother noticed on 26-SEP-2006.  The rash consisted of vesicles and papules and was erythematous. The patient experienced pain on percussion of the left flank. She had fluid filled vesicles in rosette pattern over the left side of mons pubis with erythematous papules extending from midline to side. Also with vesicles and erythematous papules over lower left side and lower back. The patient's pain in back did correlate with the area of the rash. The patient was treated with ibuprofen (MOTRIN) 100mg/5ml 2 tsp po/6h as needed, acetaminophen (TYLENOL) and diphenhydramine hydrochloride (BENADRYL). The patient did not have a history of varicella. A skin scraping was taken on 27-SEP-2005 for HSV Antigen Detection (result-negative), HSV PCR (result-negative), VZV Antigen Detection (result-positive), VZV PCR (result-positive) and fungal dermatophyte screen. A urinalysis by dip was performed in the office, the result was normal. The patient was diagnosed with Varicella zoster. The patient was seen in the office on 28-SEP-2006 for a recheck. Since yesterday the rash had gotten worse, the papules developed into vesicles, but the pain had remained the same and was improving with acetaminophen (TYLENOL)/ibuprofen (MOTRIN). There was no spreading of the rash to other areas. There were no new fevers. The was an occasional cough. She still experienced tenderness over the left flank area, had multiple grouped vesicles in the L1 dermatomal distribution and shotty cerival adenopathy. It was reported that in the mouth prior to the zoster she received fluticasone propionate (FLOVENT) 44mcg/act in aero 2 puffs bid, albuterol 90 mcg/act in aero 2 puffs every 4 hours as needed and iron 475 mg PO. No outcome was reported. Additional information is not expected.
Age: 5.0
Sex: F
Vaccine: VARCEL
Symptoms: Urine analysis normal, Varicella zoster virus serology positive
Clinical narrative: Information has been received from a physician concerning a 5-year-old female with asthma, anaemia who no known allergies, who on 18-SEP-2001 was vaccinated in the right thigh with a first dose of Varivax (lot# 638497/1905K). There was no illness at the time of vaccination. On 26-SEP-2005 the patient developed left thigh and vaginal area vesicular rash associated with fever, back pain and an upper respiratory infection. The rash was described as being in the L1 dermatome, it started on the left thigh and vaginal area and was localized in the L1 dermatome. The lesions were mostly vesicular, there were not hemorrhagic or itchy. They were painful, with a pain score of 4 on the Wong Baker Scale. It was not known how many spots the patient had. On 27-SEP-2005 in the morning the patient presented with a low grade fever of 99.7, as well as with complaints of back pain in the morning for two days in a row. She had a cough and runny nose, a rash on thigh, and vaginal area that the patient's mother noticed on 26-SEP-2006.  The rash consisted of vesicles and papules and was erythematous. The patient experienced pain on percussion of the left flank. She had fluid filled vesicles in rosette pattern over the left side of mons pubis with erythematous papules extending from midline to side. Also with vesicles and erythematous papules over lower left side and lower back. The patient's pain in back did correlate with the area of the rash. The patient was treated with ibuprofen (MOTRIN) 100mg/5ml 2 tsp po/6h as needed, acetaminophen (TYLENOL) and diphenhydramine hydrochloride (BENADRYL). The patient did not have a history of varicella. A skin scraping was taken on 27-SEP-2005 for HSV Antigen Detection (result-negative), HSV PCR (result-negative), VZV Antigen Detection (result-positive), VZV PCR (result-positive) and fungal dermatophyte screen. A urinalysis by dip was performed in the office, the result was normal. The patient was diagnosed with Varicella zoster. The patient was seen in the office on 28-SEP-2006 for a recheck. Since yesterday the rash had gotten worse, the papules developed into vesicles, but the pain had remained the same and was improving with acetaminophen (TYLENOL)/ibuprofen (MOTRIN). There was no spreading of the rash to other areas. There were no new fevers. The was an occasional cough. She still experienced tenderness over the left flank area, had multiple grouped vesicles in the L1 dermatomal distribution and shotty cerival adenopathy. It was reported that in the mouth prior to the zoster she received fluticasone propionate (FLOVENT) 44mcg/act in aero 2 puffs bid, albuterol 90 mcg/act in aero 2 puffs every 4 hours as needed and iron 475 mg PO. No outcome was reported. Additional information is not expected.
Age: 9.0
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster, Rash maculo-papular, Rash pruritic
Clinical narrative: Information has been received from a physician concerning a 9-year-old female who  on 14-JAN-1997 was vaccinated with a dose of Varivax. On 02-JUL-2005 the patient developed an itchy maculopapular dermatomal rash (T8) and was taken to the ER where he diagnosed with zoster and treated with acyclovir. Subsequently, the patient recovered from zoster.  Additional information has been requested.
Age: 1.42
Sex: M
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Information has been received from a physician concerning a 17-month-old male with no pre-existing allergies, birth defects or medical conditions, who on 02-FEB-2005 was vaccinated in the right arm with a first dose of Varivax (lot# 649481/0764P). There was no illness at the time of vaccination. It was unknown if there were concomitant vaccinations. On 15-MAY-2005 the patient developed a vesicular rash (at C5). It was unknown if medical attention was sought. No laboratory or diagnostic tests were performed. The patient was treated with acetaminophen (TYLENOL). Subsequently, the patient recovered. Additional information is not expected.
Age: 19.0
Sex: M
Vaccine: VARCEL
Symptoms: Body temperature increased, Herpes zoster, Inappropriate schedule of drug administration, Injection site rash
Clinical narrative: Information has been received from a physician concerning a 19-year-old male student with allergies to amoxicillin and gadolium, and a history of synovial cell sarcoma diagnosed in 2003 who on 14-FEB-2005 was vaccinated with a first dose of Varivax (lot# 649482/0765P). There was no concomitant medication. In January 2006, the patient developed a rash consistent with herpes zoster as diagnosed by the pediatrician who vaccinated the patient. The patient was seen in the reporting physician's office on 03-APR-2006. The patient subsequently recovered. No product quality complaint was involved. Additional information received from a physician indicated that the patient was vaccinated in the right arm a second dose of Varivax (lot # 647715/0190P) on 26-JUL-2005. The patient was reported to have an injection site reaction, it was not specified with which dose. On 31-MAY-2006 the patient also developed an axillary rash with numerous lesions, maximum temperature was 98.8, and it was considered to be herpes zoster. It was reported that the patient did not have a recent exposure to chickenpox or shingles. A specimen was obtained for PCR analysis on 31-MAY-2006 from a lesion of a "maculopapular rash". It was reported that the specimen was inadequate, negative for B-Globin, and there was no strain ID. No additional information is expected.
Age: 1.0
Sex: F
Vaccine: HIBV, VARCEL
Symptoms: Allergy test, Pyrexia, Rash erythematous, Rash generalised, Rash maculo-papular
Clinical narrative: Information has been received from a physician concerning a 12 month old female with severe right brachial plexus from birth and a history of reconstructive surgery who on 21-FEB-2006 at 2 pm was vaccinated SC in the left thigh with a first dose of Varivax (lot # 646547/0392r). Suspect vaccination administered that day at 2 pm included a fourth dose in the left thigh of HIB vaccine (unspecified) (manufacturer unknown) (lot  UE760AA). It was noted that the patient had finished amoxicillin three days prior given on 16-FEB-2006 for otitis media. Thrity hours after vaccination, on 22-FEB-2006 at 7 pm, the patient developed generalized urticaria on her lower abdomen, thighs, and buttocks. It was reported that the patient also developed a generalized rash on her thighs, lower abdomen, and groin 30 hours post vaccination. She was treated with diphenhydramine hydrochloride (BENADRYL) and hydroxyzine hydrochloride (ATARAX). The symptoms resolved in 15 hours. The urticaria resolved on 23-FEB-2006. On 17-MAR-2006 (previously reported as two weeks after vaccination) the patient developed a fever of 102F and 3 erythematous maculopapular spots on her torso also described as a maculopapular red rash with three spots. She was treated with (TYLENOL) and the symptoms resolved. The patient's fever resolved within 2.5 days. The patient recovered on 20-MAR-2006. Unspecified medical attention was sought. Allergy testing was done. A skin prick was negative for MMR II, Varivax, gelatin. An intra dermal test was not done. There was no product quality complaint involved. The patient's adverse events were considered to be other important medical events by the reporter. Additional information is not expected.
Age: 1.0
Sex: F
Vaccine: HIBV, VARCEL
Symptoms: Urticaria
Clinical narrative: Information has been received from a physician concerning a 12 month old female with severe right brachial plexus from birth and a history of reconstructive surgery who on 21-FEB-2006 at 2 pm was vaccinated SC in the left thigh with a first dose of Varivax (lot # 646547/0392r). Suspect vaccination administered that day at 2 pm included a fourth dose in the left thigh of HIB vaccine (unspecified) (manufacturer unknown) (lot  UE760AA). It was noted that the patient had finished amoxicillin three days prior given on 16-FEB-2006 for otitis media. Thrity hours after vaccination, on 22-FEB-2006 at 7 pm, the patient developed generalized urticaria on her lower abdomen, thighs, and buttocks. It was reported that the patient also developed a generalized rash on her thighs, lower abdomen, and groin 30 hours post vaccination. She was treated with diphenhydramine hydrochloride (BENADRYL) and hydroxyzine hydrochloride (ATARAX). The symptoms resolved in 15 hours. The urticaria resolved on 23-FEB-2006. On 17-MAR-2006 (previously reported as two weeks after vaccination) the patient developed a fever of 102F and 3 erythematous maculopapular spots on her torso also described as a maculopapular red rash with three spots. She was treated with (TYLENOL) and the symptoms resolved. The patient's fever resolved within 2.5 days. The patient recovered on 20-MAR-2006. Unspecified medical attention was sought. Allergy testing was done. A skin prick was negative for MMR II, Varivax, gelatin. An intra dermal test was not done. There was no product quality complaint involved. The patient's adverse events were considered to be other important medical events by the reporter. Additional information is not expected.
Age: 35.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Blood immunoglobulin G, Blood immunoglobulin M, Headache, Influenza like illness, Laboratory test
Clinical narrative: Information has been received from a registered nurse concerning a 35 year old female health care worker with a history of childhood non-hodgkins lymphoma who on 06-FEB-2006 at 10:30 was vaccinated SC in the left arm with a first dose of Varivax (lot # 646539/0551R). Concomitant vaccination the same day included a first dose of MMR II (lot # 649514/0936P) given SC in the right arm. There was no illness at the time of vaccination. Subsequently, the patient developed a vesicular rash, fever and flu like symptoms. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information from the registered nurse indicated that the patient with a history of childhood Non-Hodgkins Lymphoma was vaccinated SC in the left arm with a second dose of MMR II (lot # 649514/0936P) on 08-MAR-2006 at 13:15. On 22-MAR-2006 at 14:00 the patient developed a vesicular type rash over her body associated with muscle aches and headache. The rash resolved on 14-APR-2006. The patient was seen by the infection control physician and returned to work on 17-APR-2006. It was reported that the varicella IgG was 788 and IgM was 66. No further information is expected.
Age: 35.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Myalgia, Pyrexia, Rash vesicular, Varicella
Clinical narrative: Information has been received from a registered nurse concerning a 35 year old female health care worker with a history of childhood non-hodgkins lymphoma who on 06-FEB-2006 at 10:30 was vaccinated SC in the left arm with a first dose of Varivax (lot # 646539/0551R). Concomitant vaccination the same day included a first dose of MMR II (lot # 649514/0936P) given SC in the right arm. There was no illness at the time of vaccination. Subsequently, the patient developed a vesicular rash, fever and flu like symptoms. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information from the registered nurse indicated that the patient with a history of childhood Non-Hodgkins Lymphoma was vaccinated SC in the left arm with a second dose of MMR II (lot # 649514/0936P) on 08-MAR-2006 at 13:15. On 22-MAR-2006 at 14:00 the patient developed a vesicular type rash over her body associated with muscle aches and headache. The rash resolved on 14-APR-2006. The patient was seen by the infection control physician and returned to work on 17-APR-2006. It was reported that the varicella IgG was 788 and IgM was 66. No further information is expected.
Age: 1.3
Sex: M
Vaccine: VARCEL
Symptoms: Rash papular, Rash vesicular
Clinical narrative: Information has been received from a physician concerning a 16 month old black male, with no medical history and no allergies, who on 01-FEB-2006 was vaccinated with a first subcutaneous dose of Varivax (Lot# 651052/0562R). There was no concomitant medication. There was no illnesses at the time of vaccination and there was no adverse event following prior vaccination. ON 13-FEB-2006, in the morning, the patient developed papules and a papular vesicular rash, with some umbilicated over the body. It was noted that the patient had 15 lesions at the time of the examination, thirteen days after the vaccination. It was noted that the patient also had a fever. The patient recovered on 18-MAR-2006. Additional information is not expected.
Age: 15.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site pruritus, Injection site vesicles
Clinical narrative: Information has been received from a nurse practitioner concerning a 15 year old male who on 03-APR-2006 at 9:00am was vaccinated SC with 0.5 mL first dose of Varivax (lot# 0647538/0784R). There was no illness at the time of vaccination. On 03-APR-2006 (also reported as 05-APR-2006 for the erythema), within 24 hours after vaccination, the patient developed injection-site complaints which included soreness, erythema, induration, "local heat", pruritis and what appeared to be a pus filled vesicular lesion. The patient's outcome was reported as recovering. Follow-up information from the nurse practitioner indicated that on 05-APR-2005 the patient developed an infection. The outcome of the patient's infection was unknown. There was no product quality complaint involved. Additional information is not expected.
Age: 15.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site warmth
Clinical narrative: Information has been received from a nurse practitioner concerning a 15 year old male who on 03-APR-2006 at 9:00am was vaccinated SC with 0.5 mL first dose of Varivax (lot# 0647538/0784R). There was no illness at the time of vaccination. On 03-APR-2006 (also reported as 05-APR-2006 for the erythema), within 24 hours after vaccination, the patient developed injection-site complaints which included soreness, erythema, induration, "local heat", pruritis and what appeared to be a pus filled vesicular lesion. The patient's outcome was reported as recovering. Follow-up information from the nurse practitioner indicated that on 05-APR-2005 the patient developed an infection. The outcome of the patient's infection was unknown. There was no product quality complaint involved. Additional information is not expected.
Age: 1.2
Sex: M
Vaccine: VARCEL
Symptoms: Rash papular, Rash vesicular, Scab
Clinical narrative: Information has been received from a physician concerning a 12-month-old black male with no pre-existing allergies, birth defects, or medical conditions who on 27-MAR-2006 was vaccinated SC in the right thigh with a first dose of Varivax (Lot # 652550/1111R). There was no illness at the time of vaccination. There was no concomitant medication. ON 12-APR-2006, approximately one week post vaccination, the patient broke out in a papular and vesicular rash over his chest, neck, and head. Later, a lesion was on his arm. At the time of the exam, the patient had multiple scabbed lesions over his chest, back, neck and behind his ears. The outcome was recovered on 16-APR-2006. There were no adverse events following prior vaccinations. Additional information has been requested.
Age: 39.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Pruritus, Pyrexia
Clinical narrative: Information has been received from a health professional concerning a 39-year-old male with no known medical history or allergies who on 19-APR-2006 was vaccinated SC with a 0.5 ml dose of Varivax (lot # 652454/1017R) because he had a negative varicella titer (22-FEB-2006). There was no concomitant medication. In the night of 02-MAY-2006 the patient developed a fever, though his temperature was not taken. On 03-MAY-2006 the patient experienced chickenpox breakthrough. On 03-MAY-2006 his arm was red, warm and swollen with red raised areas by the injection site with a fever (unrecorded) the night before. On 08-MAY-2006 the patient presented with pox marks and fluid filled blisters with fever and itching. On 10-MAY-2006 the patient had three new poxes. He was not allowed to work from 08-MAY-2006 until 12-MAY-2006 when the lesions were dry and scabbed up. The event was less than 50 lesions and the patient had no further complications. He took ibuprofen for the fever and diphenhydramine hydrochloride (BENADRYL) for the itching. The patient was considered recovered on 12-MAY-2006 when all of the sites were dry and crusty. There was no product quality complaint involved. Additional information is not expected.
Age: 39.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a health professional concerning a 39-year-old male with no known medical history or allergies who on 19-APR-2006 was vaccinated SC with a 0.5 ml dose of Varivax (lot # 652454/1017R) because he had a negative varicella titer (22-FEB-2006). There was no concomitant medication. In the night of 02-MAY-2006 the patient developed a fever, though his temperature was not taken. On 03-MAY-2006 the patient experienced chickenpox breakthrough. On 03-MAY-2006 his arm was red, warm and swollen with red raised areas by the injection site with a fever (unrecorded) the night before. On 08-MAY-2006 the patient presented with pox marks and fluid filled blisters with fever and itching. On 10-MAY-2006 the patient had three new poxes. He was not allowed to work from 08-MAY-2006 until 12-MAY-2006 when the lesions were dry and scabbed up. The event was less than 50 lesions and the patient had no further complications. He took ibuprofen for the fever and diphenhydramine hydrochloride (BENADRYL) for the itching. The patient was considered recovered on 12-MAY-2006 when all of the sites were dry and crusty. There was no product quality complaint involved. Additional information is not expected.
Age: 1.5
Sex: F
Vaccine: VARCEL
Symptoms: Culture throat negative, Headache, Pharyngolaryngeal pain, Streptococcal identification test negative, Varicella
Clinical narrative: Information has been received from a registered nurse concerning an 11 year old white female with no known medical history or allergies who on 19-AUG-1996 was vaccinated with a 0.5 mL SC first dose of Varivax (lot #617219/0250D). There was no concomitant medication. There was no illness at the time of vaccination. ON 01-JUN-2006 the patient developed chickenpox lesions. On 06-JUN-2006 the patient was seen in the office with vomiting, headache, and sore throat. A rapid strep test and throat culture was negative for strep throat. The patient's mother stated that 7 classmates have had chickenpox so far. On 15-JUN-2006 the patient recovered. The patient had no adverse events following prior vaccination. Additional information is not expected.
Age: 1.5
Sex: F
Vaccine: VARCEL
Symptoms: Vomiting
Clinical narrative: Information has been received from a registered nurse concerning an 11 year old white female with no known medical history or allergies who on 19-AUG-1996 was vaccinated with a 0.5 mL SC first dose of Varivax (lot #617219/0250D). There was no concomitant medication. There was no illness at the time of vaccination. ON 01-JUN-2006 the patient developed chickenpox lesions. On 06-JUN-2006 the patient was seen in the office with vomiting, headache, and sore throat. A rapid strep test and throat culture was negative for strep throat. The patient's mother stated that 7 classmates have had chickenpox so far. On 15-JUN-2006 the patient recovered. The patient had no adverse events following prior vaccination. Additional information is not expected.
Age: 11.0
Sex: F
Vaccine: VARCEL
Symptoms: Headache, Pyrexia, Skin lesion, Varicella
Clinical narrative: Information has been received from a health professional and a mother concerning her 11-year-old daughter with no pertinent medical history, including no past drug reactions or allergies or potentially noxious or environmental factors who on 24-JUL-1997 was vaccinated SC in the left arm with a 0.5mL first dose of Varivax (Lot # 622749/0544E). There was no illness at the time of vaccination. There was no concomitant medication. On 01-JUN-2006 the patient experienced chicken pox lesions (no less than 100 lesions), fever, and a headache. At the time of the report, it was noted that the lesions were crusted, and that the patient was recovering. Follow up information received from a registered nurse indicated that the patient recovered on 08-JUN-2006. There were no relevant diagnostic tests or laboratory data. There were no adverse events following prior vaccinations of the patient or siblings. No additional information is expected.
Age: 8.0
Sex: F
Vaccine: VARCEL
Symptoms: Pruritus, Rash vesicular, Wound drainage
Clinical narrative: Information has been received from a physician concerning an 8-year-old female with no pertinent medical history who on 03-MAY-2006 was vaccinated SC with a 0.5mL dose of Varivax (Lot # 650389/0915R). Concomitant therapy included POLY-VI-FLOR TABLETS. On 22-MAY-2006 the patient developed lesions. The patient was seen in the office on 24-MAY-2006, and about 8-9 lesions were noted on the torso and some on the scalp. These lesions were pruritic and oozing. The outcome was reported as recovering. Unspecified medical attention was sought. There was no product quality complaint. No further information was available. Additional information has been requested.
Age: 1.5
Sex: F
Vaccine: DTAP, VARCEL
Symptoms: Herpes zoster, Pain, Pruritus, Rash papular, Rash vesicular
Clinical narrative: Information has been received from a physician concerning a 5 year old white female with no known allergies, and a history of mild speech and motor delays who, on 26 Sep 2002, was vaccinated SC in the left arm with a first dose of Varivax (lot# 641157/0079M). Concomitant vaccination included a fourth dose of Infanrix (lot# 566A2). There was no illness at the time of vaccination. On 27 Jul 2006, the patient developed shingles and was seen by the physician with a unilateral rash consisting of vesicles and papules on the left trunk and axilla. The patient complained of pain (+1) and an itch. No diagnostic tests or labs were performed. The patient was placed on amoxicillin + Augmentin. Subsequently, the patient recovered. It was reported that the patient had not had any adverse events following prior vaccination. There was no product quality compliant involved. Additional information is not expected.
Age: 10.0
Sex: F
Vaccine: HEPA, VARCEL
Symptoms: Injection site induration
Clinical narrative: Information has been received from a medical assistant concerning a 10 year old female with an allergy to nickel and no other medical history who on 03-AUG-2006 at 11:00 was vaccinated SC in the right arm with a second dose of Varivax (lot# 653965/0591F). Concomitant vaccination included a first dose of VAQTA (lot# 654337/0510F) given IM in the right arm. There was no illness at the time of vaccination. At approximately 08:00 on 04-AUG-2006 the patient developed a 3.5 inch by 3 inch red indurated area on her right posterior arm. The patient was treated with topical hydrocortisone cream, ice and oral BENADRYL. There were no diagnostic tests or labs performed. It was reported that the patient has not had adverse events following prior vaccination. There was no product quality complaint involved. Additional information is not expected.
Age: 11.0
Sex: F
Vaccine: HEPA, VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from a medical assistant concerning an 11 year old female with an Amoxil allergy and no other pertinent medical history who on 02 Aug 2006 at 13:45 was vaccinated SC in the right posterior arm with a dose of Variavax (lot# 653965/0591F). Concomitant vaccination included a dose of Hep A (lot #654337/0510F) given IM. On 02 Aug 2006 at 20:30 the patient developed a 1 3/4 inch x 1 3/4 inch red indurated area on his right posterior arm injection site, with local heat and swelling. He was treated with Benadryl and a topical hydrocortisone cream. Subsequently, the patient recovered. There was no product quality complaint involved. Additional information is not expected.